成都高新区与四川发展（控股）公司签约！共筑医药健康产业发展新高地

Core Viewpoint - The collaboration between Chengdu High-tech Zone and Sichuan Development (Holding) Company aims to enhance the pharmaceutical and health industry in Sichuan Province through equity cooperation, fund establishment, talent exchange, and innovation incubation [2]. Group 1: Collaboration Details - The partnership will focus on key areas such as pharmaceuticals, medical devices, medical services, and digital healthcare [2]. - The initiative includes the establishment of industry funds, attraction of quality projects, co-construction of incubation platforms, and talent cultivation to strengthen the pharmaceutical health industry in Sichuan [2]. Group 2: Future Plans - Both parties plan to further enhance cooperation in the biopharmaceutical sector, promoting resource sharing and collaborative development [2]. - The goal is to build a globally influential and competitive biopharmaceutical innovation hub, injecting new momentum into the high-quality development of the industry in the province [2]. Group 3: Previous Collaborations - Chengdu High-tech Zone and Sichuan Development (Holding) Company have a solid foundation of cooperation, having worked together since 2022 on investments in chemical drugs, medical equipment, and pharmaceutical outsourcing services [2]. - The partnership has successfully completed the acquisition of Hongming Bosi Pharmaceutical by Sichuan Biopharmaceutical Group and has nurtured several listed companies and local star enterprises [2]. Group 4: Commitment to Support - Chengdu High-tech Zone is committed to providing the best environment and services to support the growth of enterprises and ensure the effective implementation of collaborative projects [3].